Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
Taylor J AikenChristopher C StahlPatrick B SchwartzJames R BarrettAlexandra W AcherDeborah LemasterGlen LeversonSharon WeberHeather NeumanDaniel E AbbottPublished in: Journal of surgical oncology (2020)
In patients with a higher risk of thin melanoma, SLNB is associated with increased cost despite a low likelihood of SLN positivity. These data better inform patient-provider discussions as the role of SLNB in thin melanoma evolves.